SLGL
Sol Gel Technologies LtdNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$238.33M
P/E Ratio
—
EPS
$-0.30
Beta
1.13
52W High
$97.97
52W Low
$6.91
50-Day MA
$73.25
200-Day MA
$56.23
Dividend Yield
—
Profit Margin
-5.66%
Forward P/E
9.34
PEG Ratio
—
About Sol Gel Technologies Ltd
Sol-Gel Technologies Ltd., a specialty clinical-stage pharmaceutical company, is focused on developing and commercializing topical dermatological pharmaceuticals based on its Israel-patented microencapsulation delivery system. The company is headquartered in Ness Ziona, Israel.
Fundamentals
| Revenue (TTM) | $18.46M |
| Gross Profit (TTM) | $1.72M |
| EBITDA | $-2.30M |
| Operating Margin | -3569.00% |
| Return on Equity | -2.92% |
| Return on Assets | -3.47% |
| Revenue/Share (TTM) | $6.60 |
| Book Value | $15.72 |
| Price-to-Book | 4.67 |
| Price-to-Sales (TTM) | 12.91 |
| EV/Revenue | 10.19 |
| EV/EBITDA | 0.23 |
| Quarterly Earnings Growth (YoY) | 487.60% |
| Quarterly Revenue Growth (YoY) | -89.50% |
| Shares Outstanding | $3.25M |
| Float | 533,990 |
| % Insiders | 59.70% |
| % Institutions | 41.73% |
Historical Volatility
HV 10-Day
64.16%
HV 20-Day
77.83%
HV 30-Day
74.82%
HV 60-Day
95.93%
HV Rank
—
Volatility is currently contracting
More HEALTHCARE Stocks
Data last updated: 6/13/2026